MediJussen: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MediJussen
Largest movements
- Cash +€77,930
up €77,930 (+84.3%), from €92,423 to €170,353
mainly Net result for the year (+€66,691) and Tax, wage and social debts (+€17,219)
- Receivables within one year +€10,317
up €10,317 (+637.0%), from €1,620 to €11,936
of which Other amounts receivable: +€11,729
- Profit (loss) carried forward +€66,691
up €66,691 (+399.6%), from €16,690 to €83,381
- Tax, wage and social debts +€17,219
up €17,219 (+53.4%), from €32,262 to €49,481
- Accrued charges and deferred income +€2,100
new in 2025: €2,100
- Gross operating margin -€12,058
down €12,058 (-12.3%), from €98,375 to €86,318
- Taxes -€7,699
down €7,699 (-30.2%), from €25,490 to €17,791
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €104,630 | €191,351 | +€86,721 | +82.9% |
| Fixed assets | 21/28 | €7,787 | €5,887 | -€1,900 | -24.4% |
| Tangible fixed assets | 22/27 | €7,787 | €5,887 | -€1,900 | -24.4% |
| Plant, machinery and equipment | 23 | €7,787 | €5,887 | -€1,900 | -24.4% |
| Current assets | 29/58 | €96,843 | €185,464 | +€88,621 | +91.5% |
| Amounts receivable within one year | 40/41 | €1,620 | €11,936 | +€10,317 | +637.0% |
| Trade receivables | 40 | €1,413 | - | -€1,413 | |
| Other amounts receivable | 41 | €207 | €11,936 | +€11,729 | +5661.3% |
| Cash at bank and in hand | 54/58 | €92,423 | €170,353 | +€77,930 | +84.3% |
| Deferred charges and accrued income | 490/1 | €2,799 | €3,174 | +€375 | +13.4% |
| Total equity and liabilities | 10/49 | €104,630 | €191,351 | +€86,721 | +82.9% |
| Equity | 10/15 | €72,236 | €138,926 | +€66,691 | +92.3% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €54,545 | €54,545 | = | 0.0% |
| Distributable reserves | 133 | €54,545 | €54,545 | = | 0.0% |
| Profit (loss) carried forward | 14 | €16,690 | €83,381 | +€66,691 | +399.6% |
| Amounts payable | 17/49 | €32,394 | €52,425 | +€20,030 | +61.8% |
| Amounts payable within one year | 42/48 | €32,394 | €50,325 | +€17,930 | +55.4% |
| Trade debts | 44 | - | €714 | +€714 | |
| Suppliers | 440/4 | - | €714 | +€714 | |
| Taxes, remuneration and social security | 45 | €32,262 | €49,481 | +€17,219 | +53.4% |
| Taxes | 450/3 | €32,262 | €49,481 | +€17,219 | +53.4% |
| Other amounts payable | 47/48 | €133 | €130 | -€2 | -1.8% |
| Accrued charges and deferred income | 492/3 | - | €2,100 | +€2,100 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,713 | €1,900 | +€187 | +10.9% |
| Other operating charges | 640/8 | - | €444 | +€444 | |
| Gross operating margin | 9900 | €98,375 | €86,318 | -€12,058 | -12.3% |
| Operating profit (loss) | 9901 | €96,663 | €83,973 | -€12,689 | -13.1% |
| Financial income | 75/76B | €207 | €679 | +€472 | +227.9% |
| Recurring financial income | 75 | €207 | €679 | +€472 | +227.9% |
| Financial charges | 65/66B | €144 | €171 | +€27 | +18.7% |
| Recurring financial charges | 65 | €144 | €171 | +€27 | +18.7% |
| Profit (loss) for the period before taxes | 9903 | €96,726 | €84,481 | -€12,244 | -12.7% |
| Income taxes | 67/77 | €25,490 | €17,791 | -€7,699 | -30.2% |
| Profit (loss) for the period | 9904 | €71,236 | €66,691 | -€4,545 | -6.4% |
| Profit (loss) for the period to be appropriated | 9905 | €71,236 | €66,691 | -€4,545 | -6.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.